ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1666

TNF-mediated Pulmonary Hypertension Is Marked by Aberrant Bone Morphogenic Protein (BMP) and Integrin/Basement Membrane Ligand-Receptor Signaling

Javier Rangel-Moreno1, Maria de la Luz Garcia-Hernandez2, Qingfu Xu3 and Benjamin Korman1, 1University of Rochester, Rochester, NY, 2University of Rochester, West Henrietta, NY, 3University of Rochester Medical Center, Rochester, NY

Meeting: ACR Convergence 2023

Keywords: Bone Morphogenetic Protein (BMP), pulmonary, Scleroderma, Transforming Growth Factor (TGF), Tumor necrosis factor (TNF)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: Abstracts: Systemic Sclerosis & Related Disorders – Basic Science

Session Type: Abstract Session

Session Time: 4:00PM-5:30PM

Background/Purpose: : We recently described TNF-transgenic mice as a novel model of pulmonary hypertension (PH) and have shown that they express altered endothelial and mesenchymal cell populations by single-cell RNA sequencing. Mutations in BMPR2 are known to cause genetic pulmonary arterial hypertension (PAH), and loss of BMPR2 function is seen in idiopathic forms of PAH, but the role of BMP signaling in inflammatory PH has not been well characterized.

Methods: Endothelial and mesenchymal cells were isolated from lungs from TNF transgenic mice and littermate controls at 8, 14, and 20 weeks of age (n=3-5 mice per timepoint and genotype).6000-8000 cells were used for droplet-based single cell capture (10X Genomics) and RNA sequencing. Data were analyzed using multinichenetr to assess for ligand-receptor (L:R) interactions between cell types in each condition. Putative L:R interactions were confirmed using immunostaining including stains for BMPR2, BMPR1a, BMP2, BMP4, Noggin, COL4A1, and ITGA2.Representative images were taken at both central/peribronchiolar areas and peripheral lung areas. aSMA was utilized to visualize vessels and as an anatomical landmark in other immunofluorescent stains BMPR2/Nog/aSMA, BMPR1a/Nog/aSMA, BMP4/Nog/aSMA, and Bmp2/Hjv/aSMA.

Results: Ligand-receptor analysis demonstrated an impaired interaction ofBMPR2 with BMP ligands (BMP4, BM6, and BMP7) in TNF-Tg PAH lungs, leading to the establishment of an alternative maladaptive BMP signaling cascade dominated by the interaction of BMP2 with BMPR1a and HJV (Figure 1 A-D).Immunofluorescence confirmed down-regulation of BMPR2 and BMP4 in TNF-Tg relative to WT littermates and up-regulation of BMPR1a, HJV, BMP2, and Noggin in TNF-Tg lungs (Figure 1E-H). L:R interactions between basement membrane proteins (COL4A1, HSPG2), TGF-beta family proteins, and integrins increased, while a decrease in pro-angiogenic signaling was observed in TNF-Tg mice (Figure 2). Circos plot and network analysis confirmed the centrality of altered BMP signaling in TNF-mediated PH pathogenesis (Figure 3).

Conclusion: Constitutive activation of TNF leads to loss of BMPR2 signaling and formation of an alternate weaker BMP signaling profile associated with increased TGF-beta/integrin and basement membrane protein expression in the PH cellular niche. Given the centrality of BMP signaling in PAH, this suggests that TNF is a key upstream mediator of pulmonary vascular disease and might represent an essential target for modulating PAH induced by inflammation and autoimmunity.

Supporting image 1

Figure 1. Altered BMP signaling in TNF-Tg lungs is a hallmark of pulmonary hypertension. A. Ligands, receptors, cells sending and receiving signals, and the strength of the predicted interaction in WT mice. Note that BMPR2 signaling has the strongest ligand-receptor interactions in WT mice. B. Ligands, receptors, cells sending and receiving signals, and the strength of the predicted interaction in TNF-Tg mice. Note that BMP2 signals through BMPR1a and HJV but the absence of BMPR2 signaling is absent in TNF Tg lungs. C. Violin plot showing differential expression of BMPR2 in endothelial and mesenchymal cell populations. Note that BMPR2 loss is most prominent in TNF-Tg gCAP cells . D. Violin plot demonstrating differential expression of BMP2 in endothelial and mesenchymal cell populations. Note that BMP2 is over-expressed in most cell types and that it is only expressed in TNF-Tg lungs in some cells. E. Representative immunofluorescence for BMPR2, Noggin, and aSMA. F. Immunostaining for BMP1a, Noggin, and aSMA. G. Immunostaining of BMP4, Noggin, and aSMA. H. Immunostaining for BMP2, Hjv, and aSMA.

Supporting image 2

Figure 2. TNF-Tg pulmonary hypertension is associated with increased integrin/basement membrane and impaired angiogenesis signaling. A. Ligand:receptor pairs and strength of the predicted interaction in WT mice support the presence of an angiogenesis signature which is prominent in WT and not TNF-Tg mice. B. Ligand:receptor pairs and strength of the predicted interaction in TNF-Tg mice indicate over-expression of collagens and basement membrane proteins interacting with integrins. C. Violin plots demonstrating differential expression of Flt1, Tek, Col4A2, and Itga2 in endothelial and mesenchymal cell populations. D. Immunofluorescence for Col4a1 and Itga2 demonstrates significant up-regulation of these proteins in TNF-Tg lungs.

Supporting image 3

Figure 3. Network analysis demonstrates centrality of BMP signaling in TNF-mediated pulmonary hypertension. A-B. Circos plots displaying most differentially regulated ligand/receptor pairs ascertained by multinichenetr in WT lungs (A) and TNF (B) lungs; sender cells are listed on the bottom while arrows point to receiver cells on the top. C-D. Network diagram showing the gene regulatory links between ligands from sender cell types to their induced ligands/receptors in receiver cell types in WT (C) and TNF (D) conditions. Lines show if the ligand/receptor in the receiver is a potential downstream target of the ligand based on literature/database knowledge and correlation in expression across samples.


Disclosures: J. Rangel-Moreno: None; M. Garcia-Hernandez: None; Q. Xu: None; B. Korman: Teneofour, Inc, 2.

To cite this abstract in AMA style:

Rangel-Moreno J, Garcia-Hernandez M, Xu Q, Korman B. TNF-mediated Pulmonary Hypertension Is Marked by Aberrant Bone Morphogenic Protein (BMP) and Integrin/Basement Membrane Ligand-Receptor Signaling [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/tnf-mediated-pulmonary-hypertension-is-marked-by-aberrant-bone-morphogenic-protein-bmp-and-integrin-basement-membrane-ligand-receptor-signaling/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/tnf-mediated-pulmonary-hypertension-is-marked-by-aberrant-bone-morphogenic-protein-bmp-and-integrin-basement-membrane-ligand-receptor-signaling/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology